Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Maternal Domperidone and Growth of Preterm Neonates in Kabul
DRKS00022844Phase 4Not yet recruiting
- Sponsor
- Kabul University of Medical Sciences
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in preterm birth, low birth weight (LBW) and prematurity and low birth weight comparing Domperidone group with Placebo group (2 arms). Planned start Feb 2021; status: not yet recruiting.
02
Drugs
domperidone
03
Conditions
preterm birthlow birth weight (LBW)prematurity and low birth weight
Beyond the preview
Go deeper on DRKS00022844.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00022844.